导师介绍
所在位置: >> 中大名医

中大名医王景峰介绍

专家简介:

教授、主任医师、医学博士、博士生导师,中山大学首届名医,享受国务院特殊津贴。现任中山大学孙逸仙纪念医院党委书记、心血管内科主任。担任中国医师协会心律学专业委员会副主任委员、中华医学会心电生理和起搏分会心力衰竭器械治疗工作委员会副主任委员、国家卫生计生委脑卒中防治专家委员会房颤卒中防治专业委员会副主任委员、中华医学会心电生理和起搏分会常务委员、中国医师协会心血管内科医师分会常务委员、国家心血管病专家委员会委员、中国心血管疾病介入诊疗培训项目专家委员会委员、美国心律学会委员(FHRS)、广东省医学会心脏起搏与电生理分会主任委员、《中华心律失常学杂志》副总编辑、《中华医学杂志英文版》等杂志编委等。主持5项国家自然科学基金(包括重大研究计划培育项目)和其他多项卫生部临床学科重点项目及广东省自然重点项目,发表SCI论文60余篇,获多项省部级科技进步奖项。

从事心血管系统疾病的医疗、教学、科研30余年,对各种心血管疾病,包括各种疑难危重症心血管病,有非常丰富的诊治经验,尤其是在心脏器械置入(心脏起搏器、ICD和CRT/CRTD)方面有很深造诣,置入成功率高、疗效好、并发症少,居国内领先水平。

个人简历:

2008.05至今 中山大学孙逸仙纪念医院(附属第二医院)党委书记 (期间:2008.05-2016.01兼副院长)

2002.06-2008.05 中山大学孙逸仙纪念医院(附属第二医院)副院长(期间:2003.05 博士研究生导师,2004.1-2004.5美国斯坦福大学医学中心博士后研究,2005.10至今 心内科主任, 2005.10-2008.03 内科主任)

1990.07-2002.06 中山医科大学(中山大学)孙逸仙纪念医院(附属第二医院)医师(期间:1991.09-1995.06孙逸仙纪念医院心内科在职博士研究生,1991.09主治医师,1994.01讲师,1996.12副主任医师,1997.07-2002.03 内科副主任,2000.12主任医师,2002.06 教授,2001.12-2005.09心内科副主任)

1987.09-1990.06 中山医科大学孙逸仙纪念医院心内科硕士研究生

1983.08-1987.08 安徽医科大学一附院内科助教、住院医师

1978.10-1983.07 安徽医科大学医学系本科生

社会兼职:

担任:

中国医师协会心律学专业委员会副主任委员

中华医学会心电生理和起搏分会心力衰竭器械治疗工作委员会副主任委员

国家卫生计生委脑卒中防治专家委员会房颤卒中防治专业委员会副主任委员

中华医学会心电生理和起搏分会常务委员

中国医师协会心血管内科医师分会常务委员

国家心血管病专家委员会委员

中国心血管疾病介入诊疗培训项目专家委员会委员

美国心律学会委员(FHRS)

广东省医学会心脏起搏与电生理分会主任委员

《中华心律失常学杂志》副总编辑

《中华医学杂志英文版》等杂志编委等

教学情况:

本科教学工作:

大力支持并积极参与教学工作,主持“内科名师论坛”等教学活动;承担“名师带教”、实习生带教、研究生带教等临床教学工作;每年均为临床专业本科阶段学生(包括五年制、七年制及八年制)讲授《内科学》大课,获得学生好评。为第一批七年制及八年制导师,自2008年以来,一直担任临床医学长学制(八年制)内科教学组组长,每年均被不同学制学生选为研究生导师。

研究生培养:

注重研究生培养,主持多项国家自然科学基金多项、卫生部临床重点项目和广东省自然科学基金重点项目等,为研究生进行科学研究提供了充裕的经费支持。多年来直接指导研究生科研工作,指导研究生发表SCI论文60余篇;指导的博士研究生温主治曾获“教育部学术新人奖”(在校博士生最高奖项)。作为博士后导师,承担博士后研究的指导工作。其研究生毕业后多能迅速获得国家自然科学基金、教育部新世纪人才支持计划等重大科研项目支持。目前已毕业研究生超过60人,已出站博士后1人,在读博士研究生8人,硕士研究生3人。

开设的继续教育项目:

开设国家级继续医学教育项目“心房颤动消融治疗新技术应用”,每年培训学员600余人。

科研工作:

主持5项国家自然科学基金(包括重大研究计划培育项目)和其他多项卫生部临床学科重点项目及广东省自然重点项目,发表SCI论文60余篇,获多项省部级科技进步奖项。

著作、论文、成果:

学术专著:

(1) 心脏起搏、除颤及再同步化治疗,(中文翻译版),主译,人民军医出版社 2016.08

(2) Marriott实用心电图学(中文翻译版),主译,科学出版社2010.02

(3) 内科疾病临床诊断与鉴别诊断,副主编,科学技术文献出版社2007.10

(4) 急性冠脉综合征诊治临床关键技术,主编,科学技术文献出版社2009.04

(5) 心血管危重症监护治疗学,主编,广东科技出版社2004.06

(6) 紧急床边心脏起搏术,主编,广东科技出版社1997.09

主要论文成果:

1.Hydrogen sulfide suppresses endoplasmic reticulum stress-induced endothelial-to-mesenchymal transition through

Src pathway. Life Sci. 2016 Jan 1;144:208-17.

2.Validation of the ability of SYNTAX and Clinical SYNTAX scores to predict adverse cardiovascular events after stent implantation: a systematic review and meta-analysis. Angiology. 2016 Oct;67(9):820-8.

3.Effects of C-reactive protein on K(+) channel interaction protein 2 in cardiomyocytes. Am J Transl Res. 2015 May 15;7(5):922-31.

4.Prognostic Usefulness of Serum Cholesterol Efflux Capacity in Patients With Coronary Artery Disease. Am J Cardiol. 2016 Feb 15;117(4):508-14.

5.C-reactive protein can up-regulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways. Stem Cell Res Ther. 2016 Aug 16;7(1):114.

6.Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure. The International Journal of Cardiovascular Imaging. 2015 Feb;31(2):329-37.

7.Effects of C-reactive protein on K(+) channel interaction protein 2 in cardiomyocytes. Am J Transl Res. 2015,15;7(5):922-31.

8.Dyssynchronous pacing triggers endothelial-mesenchymal transition through heterogeneity of mechanical stretch in a canine model. Circ J. 2015;79(1):201-9.

9.Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials. Int J Cardiol. 2015 Jul 15;191:138-48.

10.Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction. Transl Res. 2015 Mar;165(3):387-95.

11.Tachycardia pacing induces myocardial neovascularization and mobilizes circulating endothelial progenitor cells partly via SDF-1 pathway in canines. Heart Vessels. 2016 Feb;31(2):230-40.

12.Antiproteinuric effect of angiotensin receptor blockers in normotensive patients with proteinuria: a meta-analysis of randomized controlled trials. J Renin Angiotensin Aldosterone Syst. 2014 Mar;15(1):44-51.

13.Deletion of Soluble Epoxide Hydrolase Attenuates Cardiac Hypertrophy via Down-Regulation of Cardiac Fibroblasts-Derived Fibroblast Growth Factor-2. Crit Care Med. 2014,42(5):e345-54.

14.Combination of high ankle-brachial index and hard coronary heart disease Framingham Risk Score in predicting the risk of ischemic stroke in general population. Plos One. 2014 Sep 8;9(9):e106251.

15.Short-term intensive atorvastatin therapy improves endothelial function partly via attenuating perivascular adipose tissue inflammation through 5-lipoxygenase pathway in hyperlipidemic rabbits. Chin Med J (Engl). 2014;127(16):2953-9.

16.Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure. Int J Cardiovasc Imaging. 2015 Feb;31(2):329-37.

17.Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction. Transl Res. 2015 Mar;165(3):387-95.

18.Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways. Inflammation. 2014 Jun;37(3):858-70.

19.Dyssynchronous Pacing Triggers Endothelial-Mesenchymal Transition Through Heterogeneity of Mechanical Stretch in a Canine Model. Circ J. 2015;79(1):201-9.

20.Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion. Clin Biochem. 2013 Nov;46(16-17):1694-700.

21.Optimal strategy of coronary revascularization in chronic kidney disease patients:A meta-analysis. Eur J Intern Med. 2013 Jun;24(4):354-61.

22.The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence—A population-based survey of 6898 Han participants from southern China. Preventive Medicine. 2013 Oct;57(4):345-50.

23.Hemoglobin A1c Can Identify More Cardiovascular and Metabolic Risk Profile in OGTT-Negative Chinese Population. Int J Med Sci. 2013 Jun 19;10(8):1028-34.

24.Inflammation and Oxidative Stress are Associated with the Prevalence of High Aankle-brachial Index in Metabolic Syndrome Patients without Chronic Renal Failure. Int J Med Sci. 2013;10(2):183-90.

25.Antiproteinuric effect of angiotensin receptor blockers in normotensive patients with proteinuria: a meta-analysis of randomized controlled trials. J Renin Angiotensin Aldosterone Syst. 2014 Mar;15(1):44-51.

26.Bare-Metal Stent Versus Drug-Eluting Stent in Large Coronary Arteries: Meta-Analysis of Randomized Controlled Trials. Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1087-94.

27.C-reactive protein promotes vascular endothelial dysfunction partly via activating adipose tissue inflammation in hyperlipidemic rabbits. Int J Cardiol. 2013 Oct 3;168(3):2397-403.

28.Comparison of Cardiac Stem Cells and Mesenchymal Stem Cells Transplantation on the Cardiac Electrophysiology in Rats with Myocardial Infarction. Stem Cell Rev. 2013 Jun;9(3):339-49.

29.Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction. PLoS One. 2013 Jun 14;8(6):e67242.

30.Protection of renal impairment by angiotensin II type 1 receptor blocker in rats with post-infarction heart failure. Ren Fail. 2013;35(5):766-75.

31.Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators. J Cell Mol Med. 2012 Apr;16(4):657-71.

32.Predictive value of first fasting plasma glucose compared with admission plasma glucose for undiagnosed diabetes in a stable cardiology population. Clinical Biochemistry. 2012 Sep;45(13-14):1057-63.

33.Local activation of cardiac stem cells for post-myocardial infarction cardiac repair. Journal of Cellular and Molecular Medicin. 2012 Nov;16(11):2549-63.

34.Angiotensin receptor blockers for prevention of new-onset type 2 diabetes: A meta-analysis of 59,862 patients. Int J Cardiol. 2012 Mar 8;155(2):236-42.

35.Antiproteinuric effect of angiotensin receptor blockers in normotensive patients with proteinuria: a meta-analysis of randomized controlled trials. J Renin Angiotensin Aldosterone Syst. 2014 Mar;15(1):44-51.

36.Bare-Metal Stent Versus Drug-Eluting Stent in Large Coronary Arteries: Meta-Analysis of Randomized Controlled Trials. Catheterization and Cardiovascular Interventions. 2013 Jun 1;81(7):1087-94.

37.Effect of cilostazol on the progression of carotid intima-media thickness: A meta-analysis of randomized controlled trials. Atherosclerosis. 2012 Jan;220(1):177-83.

38.Angiotensin Converting Enzyme Inhibitors for Prevention of New-onset Type 2 Diabetes Mellitus: A Meta-analysis of 72,128 Patients. Int J Cardiol. 2013 Sep 10;167(6):2605-10.

39.Cilostazol-based triple antiplatelet therapy in comparison with dual antiplatelet therapy in patients with coronary stent implantation: A meta-analysis of 5,821 patients. Cardiology. 2012 Jul 24;122(3):148-57.

40.Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress. Journal of Translational Medicine. 2012 Jun 8;10:120.

Comparison of Cardiac Stem Cells and Mesenchymal Stem Cells Transplantation on the Cardiac Electrophysiology in Rats with Myocardial Infarction. Stem Cell Reviews and Reports. 2013 Jun;9(3):339-49.

临床工作:

从事心血管系统疾病的医疗、教学、科研30余年,对各种心血管疾病,包括各种疑难危重症心血管病,有非常丰富的诊治经验,尤其是在心脏器械置入(心脏起搏器、ICD和CRT/CRTD)方面有很深造诣,置入成功率高、疗效好、并发症少,居国内领先水平。

更新时间:2017年03月22日

相关文章

  • 中山大学孙逸仙纪念医院研究生科

    电话:020-81332468,传真:020-81332608

    邮箱:graduate2@163.com

    地址:广州市沿江西路107号中山大学孙逸仙纪念医院中山楼703室

    办公时间:周一到周五 上午8:00-12:00,下午2:30-5:30